Prelude Capital Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,645
| Closed | -$1.26M | – | 1113 |
|
|
2024
Q3 | $1.26M | Buy |
+10,645
| New | +$1.26M | 0.08% | 280 |
|
|
2022
Q3 | – | Sell |
-3,525
| Closed | -$526K | – | 1495 |
|
|
2022
Q2 | $526K | Sell |
3,525
-100
| -3% | -$14.9K | 0.02% | 659 |
|
|
2022
Q1 | $618K | Sell |
3,625
-3
| -0.1% | -$511 | 0.02% | 593 |
|
|
2021
Q4 | $935K | Sell |
3,628
-4
| -0.1% | -$1.03K | 0.02% | 491 |
|
|
2021
Q3 | $991K | Sell |
3,632
-1,118
| -24% | -$305K | 0.03% | 420 |
|
|
2021
Q2 | $1.06M | Buy |
4,750
+1,400
| +42% | +$313K | 0.03% | 445 |
|
|
2021
Q1 | $366K | Sell |
3,350
-800
| -19% | -$87.4K | 0.01% | 706 |
|
|
2020
Q4 | $338K | Hold |
4,150
| – | – | 0.01% | 476 |
|
|
2020
Q3 | $287K | Buy |
4,150
+2,317
| +126% | +$160K | 0.01% | 401 |
|
|
2020
Q2 | $122K | Buy |
+1,833
| New | +$122K | 0.01% | 610 |
|